| 2012 | DJ | Bristol Sees Commercial Muscle Accelerating Sales of Bydureon |
| 2012 | | BRISTOL MYERS SQUIBB CO.: Amylin Pharmaceuticals, Inc. Shareholder Alert: Berns.. |
| 2012 | DJ | WSJ BLOG/HEALTH: A.M. Vitals: GOP Finds Ammunition In Supreme Court Ruling |
| 2012 | | AstraZeneca hungry to refill medicine cabinet |
| 2012 | | Bristol-Myers to buy Amylin for about $5.3 billion |
| 2012 | DJ | Bristol-Myers to Buy Amylin Pharmaceuticals for $5.3 Billion |
| 2012 | | BRISTOL MYERS SQUIBB CO.: Bristol-Myers Squibb and AstraZeneca Expand Diabetes .. |
| 2012 | DJ | U.S. HOT STOCK FUTURES: Hot stocks to watch |
| 2012 | DJ | U.S. Stocks See Second Day of Gains |
| 2012 | DJ | U.S. HOT STOCK FUTURES: Hot stocks to watch |
| 2012 | DJ | BRISTOL MYERS SQUIBB CO.: Brisol-Myers Adds $3 Billion to Share Buyback Program |
| 2012 | | BRISTOL MYERS SQUIBB CO.: Bristol-Myers Squibb Announces Dividend |
| 2012 | | BRISTOL MYERS SQUIBB CO.: Bristol-Myers Squibb Announces the Authorization of a.. |
| 2012 | DJ | FDA Blocks Approval of Bristol-Myers, Pfizer Blood Thinner |
| 2012 | DJ | FDA Blocks Approval of Bristol-Myers, Pfizer's Blood Thinner |
| 2012 | DJ | U.S. HOT STOCK FUTURES: Hot stocks to watch |
| 2012 | DJ | FDA Blocks Approval of Anti-Stroke Drug |
| 2012 | DJ | BRISTOL-MYERS, PFIZER: FDA Seeks More Information On Anti-Stroke Drug Eliquis |
| 2012 | | BRISTOL MYERS SQUIBB CO.: Bristol-Myers Squibb and Pfizer Receive Complete Resp.. |
| 2012 | | BRISTOL MYERS SQUIBB CO.: Bristol-Myers Squibb and Emory University Announce Pa.. |
| 2012 | DJ | Roche, AC Immune Enter Pact on Alzheimer's Drug |
| 2012 | | BRISTOL MYERS SQUIBB CO.: Scripps Research Institute Announces Five-Year Resear.. |
| 2012 | DJ | Clinical Studies Show New, Proposed J&J Diabetes Drug Cuts Blood Sugar |
| 2012 | DJ | WSJ BLOG/HEALTH: Rheumatoid Arthritis Drugs Square Off Against Humira |
| 2012 | | BRISTOL MYERS SQUIBB CO.: Bristol-Myers Squibb Foundation Announces $6 Million .. |
| 2012 | | BRISTOL MYERS SQUIBB CO.: ORENCIA® (abatacept) Demonstrates Comparable Efficacy.. |
| 2012 | DJ | Amylin is Said To Draw First-Round Bids of Up to $29/Share -Bloomberg |
| 2012 | DJ | BRISTOL MYERS SQUIBB CO.: Bristol-Myers's Nulojix Shows Positive Results In Lon.. |
| 2012 | | BRISTOL MYERS SQUIBB CO.: Bristol-Myers Squibb Presents New 4-Year Data from th.. |
| 2012 | | BRISTOL MYERS SQUIBB CO.: Investigational Anti-PD-1 Immunotherapy BMS-936558 Sh.. |
| 2012 | | BRISTOL MYERS SQUIBB CO.: Bristol-Myers Squibb to Take Part in the Goldman Sach.. |
| 2012 | DJ | WSJ BLOG/HEALTH: Basic Science: To Respond to Plavix, Don't Forget to Take It |
| 2012 | | BRISTOL MYERS SQUIBB CO.: Bristol-Myers Squibb Announces Global Collaboration w.. |
| 2012 | | BRISTOL MYERS SQUIBB CO.: Bristol-Myers Squibb to Take Part in Sanford Bernstei.. |
| 2012 | DJ | FDA Reviewer Backs Expanded Approval Of Bayer, J&J's Xarelto |
| 2012 | DJ | FDA Approves Generic Versions Of Blood-Thinning Drug Plavix |
| 2012 | DJ | FDA Approves Generic Versions Of Blood Thinning Drug Plavix |
| 2012 | | BRISTOL MYERS SQUIBB CO.: New Data from Bristol-Myers Squibb Oncology Portfolio.. |
| 2012 | | BRISTOL MYERS SQUIBB CO.: U.S. FDA Approves Bristol-Myers Squibb Devens Biologi.. |
| 2012 | | BRISTOL MYERS SQUIBB CO.: Bristol-Myers Squibb Foundation Announces $15 Million.. |
| 2012 | | BRISTOL MYERS SQUIBB CO.: Former Pro Football Coach Bill Cowher Teams Up With L.. |
| 2012 | | BRISTOL MYERS SQUIBB CO.: Bristol-Myers Squibb and Tsinghua University Enter St.. |
| 2012 | | BRISTOL MYERS SQUIBB CO.: Bristol-Myers Squibb to Present New Data on ORENCIA® .. |
| 2012 | DJ | FDA Panel Backs Gilead's HIV 'Quad' Medicine |
| 2012 | | BRISTOL MYERS SQUIBB CO.: Bristol-Myers Squibb to Present at Bank of America Me.. |
| 2012 | DJ | Teva 1Q Profit Up 13% On Branded, Generic Drug Sales |
| 2012 | | Biotech targets fight back as Big Pharma circles |
| 2012 | DJ | Pfizer Profit Falls 19% As Generics Hurt Lipitor Sales |
| 2012 | DJ | Pfizer Profit Falls 19% As Generics Hurt Lipitor Sales |
| 2012 | DJ | UPDATE: Pfizer Profit Falls 19% As Generics Hurt Lipitor Sales |
| 2012 | DJ | Pfizer Profit Falls 19% As Generics Hurt Lipitor Sales |
| 2012 | | BRISTOL MYERS SQUIBB CO.: Bristol-Myers Squibb to Present at Deutsche Bank Heal.. |
| 2012 | | BRISTOL MYERS SQUIBB CO.: Bristol-Myers Squibb Invites Public to Listen to Webc.. |
| 2012 | DJ | Bristol-Myers Gets SEC Subpoena In Foreign Bribery Probe |
| 2012 | DJ | Bristol-Myers 1Q Net Rises 12% On High Cancer Drug Sales |
| 2012 | | BRISTOL MYERS SQUIBB CO.: Bristol-Myers Squibb Delivers a Solid First Quarter w.. |
| 2012 | | Watson to buy Actavis for at least $5.6 billion |
| 2012 | DJ | CARL ICAHN: Suit Against Amylin Dropped After Talks With CEO |
| 2012 | DJ | UK Health Body Approves Novartis's Tasigna For CML |
| 2012 | DJ | Pfizer Earnings Could Get Boost On Nutrition Unit Sale |
| 2012 | DJ | Achillion Shares Slide On Results From Hepatitis C Study |
| 2012 | | Nestle wins pricey battle for Pfizer baby food unit |
| 2012 | | EXCLUSIVE: Amylin explores sale, hires bankers: sources |
| 2012 | DJ | MARKET SNAPSHOT: U.S. Stock Gains Hinge On Apple, Blue-chip Results |
| 2012 | DJ | EU Body Backs AstraZeneca, Bristol's Diabetes Drug US Rejected |
| 2012 | DJ | EU Body Backs AstraZeneca, Bristol's Diabetes Drug US Rejected |
| 2012 | DJ | Gilead, Bristol's Hepatitis C Drugs Show Promise In Study |
| 2012 | | BRISTOL MYERS SQUIBB CO.: All-Oral Hepatitis C Virus Treatment with Bristol-Mye.. |
| 2012 | | BRISTOL MYERS SQUIBB CO.: Investigational Compound Peginterferon Lambda Achieve.. |
| 2012 | DJ | WSJ BLOG/HEALTH: A.M. Vitals: Human Genome Sciences Rejects Glaxo's $2.6 Billio.. |
| 2012 | DJ | Gilead, Bristol's Hepatitis C Drugs Show Promise In Study |
| 2012 | DJ | Combination Of Gilead, Bristol-Myers Hepatitis C Drugs Show Promise In Study |
| 2012 | | BRISTOL MYERS SQUIBB CO.: All-Oral Combination of Investigational Hepatitis C (.. |
| 2012 | DJ | Generics, Unemployment Soften Rise In US Drug Spending -Report |
| 2012 | | Icahn sues Amylin, pushes for sale |
Prev.
